semaglutide salt FDA warns about compounded versions of semaglutide, used for diabetes, weight loss An Update on the Status

Between December 2024 and February 2025, 143 lawsuits were filed as part of the consolidated federal litigation against GLP-1 drug manufacturers

COA / Lab results Evidence: Clinical trial Pros Triple GLP-1 / GIP / glucagon agonism in one peptide raises energy expenditure, not appetite alone Largest weight reduction reported for an incretin-class compound (~24% at 12 mg, 48-wk phase 2) Reductions in HbA1c, visceral fat and liver-fat content across trials Once-weekly subcutaneous dosing (albumin-bound half-life) Cons GI effects require gradual multi-week dose titration Newest of the GLP-1 class phase 3 (TRIUMPH) topline only

How does Ozempic (semaglutide) work

I completely recommend it. Jeremy Klukan read the feedback correctly